Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.
about
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsIron chelation and multiple sclerosisNeuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brainSpectral editing for in vivo ¹³C magnetic resonance spectroscopyNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.Recent imaging advances in neurology.Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brainNQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.Melatonin acts as antioxidant and improves sleep in MS patients.Pathogenic implications of iron accumulation in multiple sclerosis.High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging.The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosisDairy intake is associated with brain glutathione concentration in older adults.Reversible and irreversible protein glutathionylation: biological and clinical aspects.Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.Aspirin and multiple sclerosisX-ray absorption spectroscopy at the sulfur K-edge: a new tool to investigate the biochemical mechanisms of neurodegeneration.Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivoAltered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms.Impaired glutathione synthesis in neurodegeneration.Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.The role of mitochondria in axonal degeneration and tissue repair in MS.Glutathione in multiple sclerosis: more than just an antioxidant?Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol: A NOVEL MECHANISM OF INHIBITING NEUROINFLAMMATION IN VITRO.Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis: Relation to Neurological Deficit.Measuring Cerebral and Cerebellar Glutathione in Children Using 1H MEGA-PRESS MRS.Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage.In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.Methionine metabolism and multiple sclerosis.
P2860
Q26998412-F30F252D-E646-425D-95BB-BA15D5B9EE06Q27001743-7B814DA8-67F2-48C1-970B-C8E98757031FQ28831295-CC529F7D-77B6-415B-974C-132AD134F684Q30459554-340675F5-A6BB-469F-BB85-9F032164B2DCQ30871249-EBB9C6E1-EF05-48AD-9BFB-48BF99F45DD2Q30916063-9D3914C0-7779-451F-A94C-5D8AAB592053Q31025300-34105789-C9F5-48E6-8385-39BAA02E5E01Q33617100-A8D23882-5C65-485B-A4DB-190392D3772BQ34006944-4DC56446-A8C1-4961-B54F-8785C2B713B1Q34049616-FEF7015E-4C19-4B44-B85A-500D99FFB264Q34240827-D2BCA475-AB15-4A9B-86FF-B7047E76607EQ34890688-5FF90E96-B886-4BCB-B305-5ED3EF647738Q35016254-15B615B5-8C84-45CF-9041-0613FA4CED45Q35048314-9A54B071-78A5-495C-AF7F-D3B1191DBCE1Q35594174-F0C23F09-A2B6-47FA-B141-6CA6CC431B51Q35678040-48F95FD2-D4BE-4756-B74B-FD287C40CD33Q36015551-9823BB74-EAE0-46E6-B0F1-593B373468B6Q36301419-35611AC5-8135-48D5-B65A-D5884FFDD267Q36459054-0E75009B-EEB8-4E11-ACA0-85F56C4BB647Q37291406-382C22E5-3796-4910-A829-045D56561C64Q37690997-845F086D-AE4A-4557-B9FF-355BAF2B3949Q38020826-1A18D186-526E-4A64-8BC4-13EDA841F4A6Q38212993-21564009-DD07-4AAD-98CF-5C1EA02E981AQ38716305-A451630C-F06D-419C-A394-E79739836327Q39216225-C7E965C6-CFD9-418B-A929-2091CACD899CQ47307234-498FAEBF-0022-4DBB-8D19-1E5FABE75B43Q48517106-F3651640-CF86-4ED2-B2C7-F5C87C4E1BC5Q50066373-12BE231A-1619-4A18-B386-79989463C539Q52092957-85BE8567-5855-48E4-87C1-814C29733491Q52093137-67A7B459-D753-45F2-BDEB-1E14317A0D2C
P2860
Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@en
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@nl
type
label
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@en
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@nl
prefLabel
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@en
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@nl
P2093
P2860
P921
P356
P1476
Lower levels of glutathione in ...... chemical shift imaging at 3 T.
@en
P2093
P2860
P304
P356
10.1177/1352458510384010
P577
2010-10-04T00:00:00Z